Testing the Safety of New Drugs for Glioblastoma That Has Come Back
Official title: Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This early study is testing whether some new drugs are safe for people whose glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary has come back.
Read our full plain-language summary
What the trial team says
The researchers are doing this study to find out whether the drugs ABBV-637 and ABBV-155 are safe treatments that cause few or mild side effects when given alone or in combination with ERAS-801 in people with recurrent GBM.
Key facts
- Registry number
- NCT06934889
- Stage of testing
- Phase 1
- Conditions studied
- Glioblastoma, Gliosarcoma
Where it is running
This trial lists 11 sites.
-
California
- University of California, Los Angeles (Data Collection Only) (Los Angeles)
-
Florida
- University of Miami (Data collection only) (Miami)
-
Indiana
- Indiana University (Data Collection Only) (Indianapolis)
-
New Jersey
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) (Basking Ridge)
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) (Middletown)
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) (Montvale)
-
New York
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) (Commack)
- Memorial Sloan Kettering Westchester (All Protocol Activities) (Harrison)
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) (New York)
- Memorial Sloan Kettering Nassau (Limited Protocol Activities) (Rockville Centre)
-
Vermont
- University of Vermont Medical Center (Burlington)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.